Antibodies@MOFs: An In Vitro Protective Coating for Preparation and Storage of Biopharmaceuticals

Adv Mater. 2019 Jan;31(2):e1805148. doi: 10.1002/adma.201805148. Epub 2018 Nov 27.

Abstract

Antibodies have emerged as a fast-growing category of biopharmaceuticals that have been widely applied in scientific research, medical diagnosis, and disease treatment. However, many antibodies and other biopharmaceuticals display inferior biophysical properties, such as low stability and a propensity to undergo aggregation. Enhancing the stability of biopharmaceuticals is essential for their wide applications. Here, a facile in vitro protective coating strategy based on metal-organic frameworks (MOFs) is proposed to efficiently protect antibodies against perturbation environments and quickly recover them from the MOFs before usage, which avoids introducing protective additives into the body, which may cause biosafety risks. The protected antibodies exhibit extraordinary thermal, chemical, and mechanical stabilities, and they can survive for long-term storage (>3 weeks) under severe temperature variation (4 ↔ 50 °C) at a fast ramp rate (25 °C min-1 ). More importantly, the encapsulated antibodies can be easily released as quickly as 10 s with high efficiency (≈100%) to completely remove the MOFs before use. This study paves a new avenue for the facile preparation and storage of biopharmaceuticals represented by antibodies under ambient or perturbation conditions, which may greatly broaden and promote the applications of both MOFs and biopharmaceuticals.

Keywords: antibodies; biopharmaceuticals; encapsulate; metal-organic frameworks; release.

MeSH terms

  • Antibodies / pharmacology*
  • Biological Products* / pharmacology
  • Drug Compounding
  • Drug Stability
  • Drug Storage / methods
  • Metal-Organic Frameworks*
  • Temperature

Substances

  • Antibodies
  • Biological Products
  • Metal-Organic Frameworks